Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- CRDL
- Price
- 0.96
- Stock movement up
- +0.06 (6.81%)
- Company name
- Cardiol Therapeutics Inc Class A
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Drug Manufacturers - Specialty & Generic
- Market cap
- 78.09M
- Ent value
- 69.30M
- Price/Sales
- -
- Price/Book
- 7.49
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -9.00%
- 1 year return
- -48.82%
- 3 year return
- -17.27%
- 5 year return
- -17.54%
- 10 year return
- -
Last updated: 2025-04-11
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
CRDL does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | 7.49 |
| EV to Sales | - |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 81.60M |
| EPS (TTM) | -0.40 |
| FCF per share (TTM) | -0.27 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 0.00 |
| Gross profit (TTM) | -123.53K |
| Operating income (TTM) | -30.29M |
| Net income (TTM) | -28.50M |
| EPS (TTM) | -0.40 |
| EPS (1y forward) | -0.38 |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 15.89M |
| Net receivables | 266.71K |
| Total current assets | 17.28M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 17.52M |
| Accounts payable | 0.00 |
| Short/Current long term debt | 165.98K |
| Total current liabilities | 6.95M |
| Total liabilities | 7.09M |
| Shareholder's equity | 10.43M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -19.47M |
| Capital expenditures (TTM) | 15.13K |
| Free cash flow (TTM) | -19.03M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -273.20% |
| Return on Assets | -162.67% |
| Return on Invested Capital | -272.37% |
| Cash Return on Invested Capital | -181.89% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.90 |
| Daily high | 0.96 |
| Daily low | 0.87 |
| Daily Volume | 75K |
| All-time high | 8.13 |
| 1y analyst estimate | 8.73 |
| Beta | 0.70 |
| EPS (TTM) | -0.40 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 12 May 2025 |
Downside potential
Loading...
Downside potential data
| CRDL | S&P500 | |
| Current price drop from All-time high | -88.23% | -12.89% |
| Highest price drop | -94.45% | -56.47% |
| Date of highest drop | 5 Apr 2023 | 9 Mar 2009 |
| Avg drop from high | -69.81% | -11.07% |
| Avg time to new high | 112 days | 12 days |
| Max time to new high | 1541 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
78.09M
Marketcap category
Small-cap
Description
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase II multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.
Employees
0
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page